Antimicrobials targeting cell wall biosynthesis are generally considered inactive against nonreplicating bacteria. Paradoxically, we found that under nonpermissive growth conditions, exposure of Mycobacterium bovis BCG bacilli to such antimicrobials enhanced their survival. We identified a transcriptional regulator, RaaS (for regulator of antimicrobial-assisted survival), encoded by bcg1279 (rv1219c) as being responsible for the observed phenomenon. Induction of this transcriptional regulator resulted in reduced expression of specific ATP-dependent efflux pumps and promoted long-term survival of mycobacteria, while its deletion accelerated bacterial death under nonpermissive growth conditions in vitro and during macrophage or mouse infection. These findings have implications for the design of antimicrobial drug combination therapies for persistent infectious diseases, such as tuberculosis.
- Anti-Infective Agents
- Cell Line
- Electrophoretic Mobility Shift Assay
- Fluorescence Polarization
- Mycobacterium bovis
- Mycobacterium tuberculosis
- Journal Article
- Research Support, Non-U.S. Gov't
FingerprintDive into the research topics of 'Antimicrobial treatment improves mycobacterial survival in nonpermissive growth conditions'. Together they form a unique fingerprint.
- Research Centre for Sport, Exercise and Life Sciences - Associate Professor Research
Person: Teaching and Research